Grants and Contributions:
Title:
Novocol Biomanufacturing Expansion Project (COVID-19)
Agreement Number:
815860
Agreement Value:
$32,716,000.00
Agreement Date:
Mar 1, 2021 - Dec 31, 2023
Description:
This project will support the expansion of existing bio-manufacturing facilities and increasing fill-finish capacity for vaccines/therapies, including live and viral vector vaccines.
Organization:
Innovation, Science and Economic Development Canada
Location:
Cambridge, Ontario, CA N1R6X3
Reference Number:
033-2020-2021-Q4-815860
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
103950481
Recipient Type:
For-profit organization
Amendment Date
Nov 16, 2023
Recipient's Operating Name:
Novocol Pharma
Recipient's Legal Name:
Novocol Pharmaceutical of Canada Inc.
Federal Riding Name:
Cambridge
Federal Riding Number:
35016
Program:
SIF Stream 1- R&D
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
325410
Amendments: